NO832659L - Fremgangsmaate for fremstilling av antimikrobielle forbindelser. - Google Patents

Fremgangsmaate for fremstilling av antimikrobielle forbindelser.

Info

Publication number
NO832659L
NO832659L NO832659A NO832659A NO832659L NO 832659 L NO832659 L NO 832659L NO 832659 A NO832659 A NO 832659A NO 832659 A NO832659 A NO 832659A NO 832659 L NO832659 L NO 832659L
Authority
NO
Norway
Prior art keywords
procedure
preparation
antimicrobial compounds
antimicrobial
compounds
Prior art date
Application number
NO832659A
Other languages
English (en)
Other versions
NO160000C (no
NO160000B (no
Inventor
Howard Daniel Hollis Showalter
Judith L Johnson
Leslie M Werbel
Edward F Elslager
Original Assignee
Warner Lambert Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US06/507,961 external-priority patent/US4556654A/en
Application filed by Warner Lambert Co filed Critical Warner Lambert Co
Publication of NO832659L publication Critical patent/NO832659L/no
Publication of NO160000B publication Critical patent/NO160000B/no
Publication of NO160000C publication Critical patent/NO160000C/no

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C09DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
    • C09BORGANIC DYES OR CLOSELY-RELATED COMPOUNDS FOR PRODUCING DYES, e.g. PIGMENTS; MORDANTS; LAKES
    • C09B5/00Dyes with an anthracene nucleus condensed with one or more heterocyclic rings with or without carbocyclic rings
    • C09B5/02Dyes with an anthracene nucleus condensed with one or more heterocyclic rings with or without carbocyclic rings the heterocyclic ring being only condensed in peri position
    • C09B5/16Benz-diazabenzanthrones, e.g. anthrapyrimidones
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • A61P35/02Antineoplastic agents specific for leukemia
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C243/00Compounds containing chains of nitrogen atoms singly-bound to each other, e.g. hydrazines, triazanes
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D231/00Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/54Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings condensed with carbocyclic rings or ring systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D295/00Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/16Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms acylated on ring nitrogen atoms
    • C07D295/20Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms acylated on ring nitrogen atoms by radicals derived from carbonic acid, or sulfur or nitrogen analogues thereof
    • C07D295/205Radicals derived from carbonic acid

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Hematology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
NO832659A 1982-07-23 1983-07-21 Analogifremgangsm te for fremstilling av terapeutisk aktive forbindelser. NO160000C (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US40115782A 1982-07-23 1982-07-23
US06/507,961 US4556654A (en) 1983-06-28 1983-06-28 Antimicrobial substituted anthra[1,9-cd]pyrazol-6(2H)-ones

Publications (3)

Publication Number Publication Date
NO832659L true NO832659L (no) 1984-01-24
NO160000B NO160000B (no) 1988-11-21
NO160000C NO160000C (no) 1989-03-01

Family

ID=27017319

Family Applications (1)

Application Number Title Priority Date Filing Date
NO832659A NO160000C (no) 1982-07-23 1983-07-21 Analogifremgangsm te for fremstilling av terapeutisk aktive forbindelser.

Country Status (18)

Country Link
EP (1) EP0103381B1 (no)
JP (2) JPH072719B2 (no)
KR (1) KR900005026B1 (no)
AR (1) AR240315A1 (no)
AU (1) AU549659B2 (no)
CA (1) CA1230115A (no)
DE (1) DE3373811D1 (no)
DK (3) DK159429C (no)
ES (3) ES524380A0 (no)
FI (1) FI82932C (no)
GR (1) GR79610B (no)
HU (1) HU195779B (no)
IE (1) IE56782B1 (no)
IL (1) IL69211A (no)
NO (1) NO160000C (no)
NZ (1) NZ205001A (no)
PH (1) PH20906A (no)
PT (1) PT77088B (no)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1251450A (en) * 1984-06-29 1989-03-21 David B. Capps Benzopyrano¬4,3,2-cd|indazole compositions and methods for their production and use
CA1251451A (en) * 1984-06-29 1989-03-21 Ellen M. Berman Benzoseleno¬4,3,2-cd|indazole compositions and methods for their production and use
US4608439A (en) * 1985-04-26 1986-08-26 Warner-Lambert Company Process for preparing substituted anthra[1,9-cd]pyrazol-6(2H)-ones
US4672129A (en) * 1986-05-05 1987-06-09 Warner-Lambert Company Process for preparing substituted anthra[1,9-cd]pyrazol-6(2H)-ones
GB9107843D0 (en) * 1991-04-12 1991-05-29 Patterson Laurence H Anti-cancer compounds
GB9107852D0 (en) * 1991-04-12 1991-05-29 Patterson Laurence H Anti-cancer compounds
CZ288366B6 (en) * 1992-09-08 2001-06-13 Univ Vermont 2-Aminoalkyl-5-aminoalkylamino substituted isoquinoindazol-6-(2H)-ones exhibiting antitumor activity, their use, pharmaceutical preparation in which they are comprised and process of their preparation
US5393886A (en) * 1993-05-05 1995-02-28 The Du Pont Merck Pharmaceutical Company Intermediates for the synthesis of anthrapyrazolone anticancer agents
US5596097A (en) * 1994-03-08 1997-01-21 The University Of Vermont Hetero-annulated indazoles
IT1277576B1 (it) * 1995-09-13 1997-11-11 Boehringer Mannheim Italia 2-2-(2-idrossietil) ammino etil -5- 2-metilammino etil ammino indazolo 4,3-gh isochinolin-6 (2h)-one come agente antitumorale
WO2008116161A2 (en) 2007-03-22 2008-09-25 The General Hospital Corporation Pyrazoloanthrone and derivatives thereof for the treatment of cancer expressing 'mullerian inhibiting substance' type ii receptor (misrii) and of excess androgen states

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH191142A (de) * 1936-02-07 1937-05-31 Chem Ind Basel Verfahren zur Herstellung eines Anthrachinonderivates.
GB470475A (en) * 1936-02-14 1937-08-16 Of Chemical Industry Soc Manufacture of dyestuffs and intermediate products
US2518150A (en) * 1946-02-01 1950-08-08 Ciba Ltd Vat dyestuffs
DE2558812C2 (de) * 1975-12-27 1987-04-30 Hoechst Ag, 6230 Frankfurt Photopolymerisierbares Gemisch

Also Published As

Publication number Publication date
FI82932C (fi) 1991-05-10
ES8504731A1 (es) 1985-04-16
DK159849C (da) 1991-05-13
GR79610B (no) 1984-10-31
FI82932B (fi) 1991-01-31
JPH072719B2 (ja) 1995-01-18
DK159849B (da) 1990-12-17
AU549659B2 (en) 1986-02-06
ES8507502A1 (es) 1985-09-01
FI832638A (fi) 1984-01-24
NO160000C (no) 1989-03-01
JPH07110829B2 (ja) 1995-11-29
DK159429C (da) 1991-03-18
EP0103381A1 (en) 1984-03-21
PT77088A (en) 1983-08-01
DK329683D0 (da) 1983-07-18
DK160251C (da) 1991-07-22
NZ205001A (en) 1986-09-10
NO160000B (no) 1988-11-21
DK430389A (da) 1989-08-31
FI832638A0 (fi) 1983-07-20
DK160251B (da) 1991-02-18
IL69211A (en) 1987-01-30
ES8507503A1 (es) 1985-09-01
ES529577A0 (es) 1985-09-01
IE831622L (en) 1984-01-23
CA1230115A (en) 1987-12-08
KR840005431A (ko) 1984-11-12
DK430289D0 (da) 1989-08-31
DK430389D0 (da) 1989-08-31
EP0103381B1 (en) 1987-09-23
JPS5951268A (ja) 1984-03-24
IL69211A0 (en) 1983-11-30
PT77088B (en) 1986-02-12
HU195779B (en) 1988-07-28
CA1251442C (no) 1989-03-21
DK329683A (da) 1984-01-24
KR900005026B1 (ko) 1990-07-18
ES524380A0 (es) 1985-04-16
AR240315A1 (es) 1990-03-30
DK430289A (da) 1989-08-31
AU1681083A (en) 1984-01-26
PH20906A (en) 1987-05-27
IE56782B1 (en) 1991-12-18
JPH07179389A (ja) 1995-07-18
DK159429B (da) 1990-10-15
ES529578A0 (es) 1985-09-01
DE3373811D1 (en) 1987-10-29

Similar Documents

Publication Publication Date Title
NO833705L (no) Fremgangsmaate for fremstilling av fenyl-piperidin-propanol-forbindelser.
NO163668C (no) Fremgangsmaate for fremstilling av immunogent kompleks.
NO162158C (no) Fremgangsmaate for fremstilling av polyolefiner.
IT8223705A0 (it) Procedimento per la preparazione di composti cianoeterociclici.
ES527776A0 (es) Procedimiento de preparacion de derivados de 1,4-dihidropiridinas.
NO813252L (no) Fremgangsmaate for fremstilling av antibakterielle cefalosporinderivater.
NO159667C (no) Fremgangsmaate for fremstilling av kikhostetoksid.
ES505472A0 (es) Procedimiento para la preparacion de compuestos frugicidas.
NO832659L (no) Fremgangsmaate for fremstilling av antimikrobielle forbindelser.
NO812519L (no) Fremgangsmaate for fremstilling av kolesterase.
NO833531L (no) Fremgangsmaate for fremstilling av 7-substituerte-3-vinyl-3-cefem-forbindelser
NO812701L (no) Fremgangsmaate for fremstilling av antibakterielle timetyl-cefalosporiner.
NO157537C (no) Fremgangsmaate for fremstilling av tioetere.
NO162018C (no) Fremgangsmaate for fremstilling av 4-metyl-5-alkyltiometylimidazoler.
NO813814L (no) Fremgangsmaate for fremstilling av monoalkyletere av hydrokinonforbindelser
NO158376C (no) Analogifremgangsmaate for fremstilling av terapeutisk virksomme rooperolforbindelser.
NO913692D0 (no) Fremgangsmaate for fremstilling av karbapenemforbindelser.
IT8122813A0 (it) Procedimento di preparazione di n-cicloesilbenzotiazol-2-solfenammi de.
NO155732C (no) Fremgangsmaate for fremstilling av kijanimicin.
ES530145A0 (es) Procedimiento de preparacion de compuestos bromados.
ES510963A0 (es) Procedimiento de preparacion de alcoxiaminohidridosilanos.
IT8019609A0 (it) Procedimento per la preparazione di composti beta-lattamici.
ES516597A0 (es) "procedimiento de preparacion de nuevos compuestos de lactama".
ES519085A0 (es) Procedimiento para la preparacion de compuestos de benzotiazol.
ES522653A0 (es) Procedimiento de preparacion de derivados de piperacina.

Legal Events

Date Code Title Description
MK1K Patent expired

Free format text: EXPIRED IN JULY 2003